Pharmaceutical Regulatory Process (35 results)

Hardcover. Condition: Fine. Dust Jacket Condition: No Jacket - as Issued. 2nd Edition. APPEARS TO BE A NEW BOOK.

Condition: As New. Unread book in perfect condition.

Condition: New. Satisfaction Guaranteed or your money back.

Condition: Brand New. New.SoftCover International edition. Different ISBN and Cover image but contents are same as US edition.Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Paperback. Condition: new. Paperback. This Second Edition examines the mechanisms and means to establish regulatory compliance for pharmaceutical products and company practices. It focuses on major legislative revisions that impact requirements for drug safety reviews, product regulatory approvals, and marketing practices. Written by top industry professionals, practicing attorneys, and FDA regulators, it includes policies and procedures that pharmaceutical companies need to implement regulatory compliance post-approval.New chapters cover: the marketing of unapproved new drugs and FDA efforts to keep them in regulatory compliancepharmacovigilance programs designed to prevent widespread safety issueslegal issues surrounding the sourcing of foreign APIsthe issues of counterfeit drugsupdates on quality standards Shipping may be from multiple locations in the US or from the UK, depending on stock availability. …

Condition: New.

Condition: New. pp. 492.

Taschenbuch. Condition: Neu. Product Quality Review Vs. Continued Process Verification (PQR [.]) | A Practical Guide for Pharmaceutical Industries in adhering with Regulatory Compliance requirements | Sanjeev Kumar | Taschenbuch | Englisch | 2021 | LAP LAMBERT Academic Publishing | EAN 9786202516365 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.…

Condition: As New. Unread book in perfect condition.

Condition: New. pp. 492.

Taschenbuch. Condition: Neu. Activated Charcoal and other impurities in API manufacturing process | Pharmaceutical ,Toxicological and regulatory implication | Mauro Luisetto (u. a.) | Taschenbuch | Englisch | 2023 | LAP LAMBERT Academic Publishing | EAN 9786207446889 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.…

Condition: New.

Condition: New. pp. 492.

Condition: New. 2019. 2nd Edition. paperback. . . . . .

Paperback. Condition: Brand New. 2nd new edition. 650 pages. 9.01x5.98x1.30 inches. In Stock.

Condition: New. 2019. 2nd Edition. paperback. . . . . . Books ship from the US and Ireland.

Paperback. Condition: new. Paperback. This Second Edition examines the mechanisms and means to establish regulatory compliance for pharmaceutical products and company practices. It focuses on major legislative revisions that impact requirements for drug safety reviews, product regulatory approvals, and marketing practices. Written by top industry professionals, practicing attorneys, and FDA regulators, it includes policies and procedures that pharmaceutical companies need to implement regulatory compliance post-approval.New chapters cover: the marketing of unapproved new drugs and FDA efforts to keep them in regulatory compliancepharmacovigilance programs designed to prevent widespread safety issueslegal issues surrounding the sourcing of foreign APIsthe issues of counterfeit drugsupdates on quality standards Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. …

Condition: As New. Unread book in perfect condition.

Condition: As New. Unread book in perfect condition.

Condition: New.

Condition: New.

Hardcover. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condition: New. In English.

Hardcover. Condition: new. Hardcover. This Second Edition examines the mechanisms and means to establish regulatory compliance for pharmaceutical products and company practices. It focuses on major legislative revisions that impact requirements for drug safety reviews, product regulatory approvals, and marketing practices. Written by top industry professionals, practicing attorneys, and FDA regulators, it includes policies and procedures that pharmaceutical companies need to implement regulatory compliance post-approval.New chapters cover: the marketing of unapproved new drugs and FDA efforts to keep them in regulatory compliancepharmacovigilance programs designed to prevent widespread safety issueslegal issues surrounding the sourcing of foreign APIsthe issues of counterfeit drugsupdates on quality standards The Pharmaceutical Regulatory Process Shipping may be from multiple locations in the US or from the UK, depending on stock availability. …

Condition: New. IRA R. BERRY is President and Founder of International Regulatory Business Consultants, L.L.C., Freehold, New Jersey, USA. Ira Berry received his M.A. in Biology from Hofstra University, Hempstead, New York, USA and his M.B.A. in Management from Adelphi .

Condition: New. The Pharmaceutical Regulatory Process Editor(s): Berry, Ira R.; Martin, Robert P. Series: Drugs and the Pharmaceutical Sciences. Num Pages: 650 pages, 35 black & white illustrations. BIC Classification: TDCW. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 30. Weight in Grams: 793. . 2008. 2nd Edition. hardcover. . . . .…

Hardcover. Condition: Brand New. 2nd edition. 650 pages. 9.10x6.00x1.20 inches. In Stock.

Condition: New. The Pharmaceutical Regulatory Process Editor(s): Berry, Ira R.; Martin, Robert P. Series: Drugs and the Pharmaceutical Sciences. Num Pages: 650 pages, 35 black & white illustrations. BIC Classification: TDCW. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 30. Weight in Grams: 793. . 2008. 2nd Edition. hardcover. . . . . Books ship from the US and Ireland.…

Hardcover. Condition: new. Hardcover. This Second Edition examines the mechanisms and means to establish regulatory compliance for pharmaceutical products and company practices. It focuses on major legislative revisions that impact requirements for drug safety reviews, product regulatory approvals, and marketing practices. Written by top industry professionals, practicing attorneys, and FDA regulators, it includes policies and procedures that pharmaceutical companies need to implement regulatory compliance post-approval.New chapters cover: the marketing of unapproved new drugs and FDA efforts to keep them in regulatory compliancepharmacovigilance programs designed to prevent widespread safety issueslegal issues surrounding the sourcing of foreign APIsthe issues of counterfeit drugsupdates on quality standards The Pharmaceutical Regulatory Process Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. …

Condition: New. Brand New. Soft Cover International Edition. Different ISBN and Cover Image. Priced lower than the standard editions which is usually intended to make them more affordable for students abroad. The core content of the book is generally the same as the standard edition. The country selling restrictions may be printed on the book but is no problem for the self-use. This Item maybe shipped from US or any other country as we have multiple locations worldwide.…